Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6941 USD | -2.24% | -2.36% | -15.53% |
05-13 | Tocagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.53% | 25.84M | |
+4.79% | 111B | |
+11.16% | 105B | |
-12.36% | 22.34B | |
-3.84% | 21.93B | |
-5.99% | 18.59B | |
-35.21% | 18.12B | |
-9.80% | 16.96B | |
+2.92% | 13.7B | |
+36.70% | 12.45B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences : Chardan Adjusts Forte Biosciences' Price Target to $115 From $110, Keeps at Buy